| Literature DB >> 5082545 |
H J Dargie, M E Allison, A C Kennedy, M J Gray.
Abstract
Metolazone is a modified quinazolinesulphonamide and in a dose of between 4 and 7.5 mg is an effective diuretic in man with normal renal function. Fourteen patients with non-oedematous stable chronic renal failure (creatinine clearance ranging from 1.2 to 12 ml/min) were given metolazone in doses ranging from 20-150 mg. A noticeable increase in urine flow and sodium excretion occurred, free water clearance increased, and there was a small but significant increase in potassium excretion. No side effects were noted.Entities:
Mesh:
Substances:
Year: 1972 PMID: 5082545 PMCID: PMC1786502 DOI: 10.1136/bmj.4.5834.196
Source DB: PubMed Journal: Br Med J ISSN: 0007-1447